Art

J-GLOBAL ID：201502211780914840   Reference number：15A1148804

Analysis of Neuropsychiatric Adverse Events in Patients Treated with Oseltamivir in Spontaneous Adverse Event Reports

自然有害事象報告におけるオセルタミビールで治療された患者での精神神経有害事象の分析

Author (9)： UEDA Natsumi (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  UMETSU Ryogo (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  ABE Junko (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  ABE Junko (Medical Database Co., Ltd.) ,  KATO Yamato (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  NAKAYAMA Yoko (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.) ,  KATO Zenichiro (Dep. of Pediatrics, Gifu Univ. Graduate School of Medicine) ,  KINOSADA Yasutomi (Dep. of Biomedical Informatics, Gifu Univ. Graduate School of Medicine) ,  NAKAMURA Mitsuhiro (Lab. of Drug Informatics, Gifu Pharmaceutical Univ.)
Material： Biological and Pharmaceutical Bulletin  (Biological & Pharmaceutical Bulletin)
Volume： 38  Issue： 10  Page： 1638-1644 (J-STAGE)  Publication year： 2015 
JST Material Number： S0989A  ISSN： 0918-6158  CODEN： BPBLEO  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： human ,...
Semi thesaurus term： Behavior abnormal ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=15A1148804&from=J-GLOBAL&jstjournalNo=S0989A") }}

JST classification (1)： Mental disorders  (GR03000A)

Substance index (1)： Oseltamivir

Reference (32)：

• 1) U.S. Department of Health and Human Services. “HHS pandemic influenza plan.2005.”: ‹http://www.flu.gov/planning-preparedness/federal/hhspandemicinfluenzaplan.pdf›, cited 17 March, 2015.
• 2) Jefferson T, Jones M, Doshi P, Spencer EA, Onakpoya I, Heneghan CJ. Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments. BMJ, 348 (apr09 2), g2545 (2014).
• 3) Fujita T, Fujii Y, Watanabe Y, Osaka H, Wada T, Mori M, Yokota S. A pharmacoepidemiologic study on the relationship between neuropsychiatric symptoms and therapeutic drugs after influenza infection. Jpn. J. Pharmacoepidemiol., 15, 73-95 (2010).
• 4) Hoffman KB, Demakas A, Erdman CB, Dimbil M, Doraiswamy PM. Neuropsychiatric adverse effects of oseltamivir in the FDA Adverse Event Reporting System, 1999-2012. BMJ, 347 (jul23 3), f4656 (2013).
• 5) Ho LN, Chung JP, Choy KL. Oseltamivir-induced mania in a patient with H1N1. Am. J. Psychiatry, 167, 350 (2010).

Terms in the title (7)： 有害事象報告 ,  オセルタミビール ,  治療 ,  患者 ,  神経 ,  有害事象 ,  分析